1123169-45-8

Basic information

• Product Name: t-Butyl 6-bromo-3,4-dihydro-2H-quinoline-1-carboxylate
• Synonyms: 1-BOC 6-bromo-3,4-dihydro-2H-quinoline;t-Butyl 6-bromo-3,4-dihydro-2H-quinoline-1-carboxylate;tert-Butyl 6-broMo-3,4-dihydroquinoline-1(2H)-carboxylate;6-Bromo-3,4-dihydro-2H-quinoline-1-carboxylic acid tert-butyl ester
• CAS NO: 1123169-45-8
• Molecular Formula: C₁₄H₁₈BrNO₂
• Molecular Weight: 312.20222
• Mol File: 1123169-45-8.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 382.0±41.0 °C(Predicted)
• Appearance: /
• Density: 1.353±0.06 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 0.02±0.20(Predicted)
• CAS DataBase Reference: t-Butyl 6-bromo-3,4-dihydro-2H-quinoline-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: t-Butyl 6-bromo-3,4-dihydro-2H-quinoline-1-carboxylate(1123169-45-8)
• EPA Substance Registry System: t-Butyl 6-bromo-3,4-dihydro-2H-quinoline-1-carboxylate(1123169-45-8)

Safety Data

• Hazardous Substances Data: 1123169-45-8(Hazardous Substances Data)

Usage

General Description

T-Butyl 6-bromo-3,4-dihydro-2H-quinoline-1-carboxylate is a chemical compound with the molecular formula C15H18BrNO2. It is an ester derivative of 6-bromo-3,4-dihydro-2H-quinoline-1-carboxylic acid, with a tert-butyl group attached to the nitrogen of the carboxylic acid group. t-Butyl 6-bromo-3,4-dihydro-2H-quinoline-1-carboxylate is commonly used in the pharmaceutical industry as an intermediate for the synthesis of various quinoline-based drugs and biologically active molecules. Its unique structure and reactivity make it a valuable building block for the preparation of diverse chemical compounds with potential therapeutic applications. Additionally, it has been studied for its potential biological activities, including antimicrobial and antifungal properties, making it a promising candidate for further exploration in medicinal chemistry and drug discovery.

Upstream product

• 22190-35-8 6-bromo-1,2,3,4-tetrahydroquinoline 
• 24424-99-5 di-tert-butyl dicarbonate 

Downstream Products

• 1912446-60-6 tert-butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroquinoline-1(2H)-carboxylate 
• 1338782-43-6 C₂₅H₃₀F₃N₃O₂ 
• 1279870-64-2 C₂₀H₂₂F₃N₃ 
• 1338782-36-7 C₃₅H₃₃F₃N₄O₅ 
• 1338782-29-8 C₃₄H₃₁F₃N₄O₅ 

Relevant articles and documents

INHIBITORS OF FIBROBLAST ACTIVATION PROTEIN

Compounds and compositions for modulating fibroblast activation protein (FAP) are described. The compounds and compositions may find use as therapeutic agents for the treatment of diseases, including hyperproliferative diseases.

GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE

Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with the enzyme glycolate oxidase (GO). Such diseases or disorders include, for example, disorders of glyoxylate metabolism, including primary hyperoxaluria, that are associated with production of excessive amounts of oxalate.

BIARYL-CONTAINING COMPOUNDS AS INVERSE AGONISTS OF ROR-GAMMA RECEPTORS

The present invention relates to biaryl-containing inverse agonists of ROR-gamma receptors. The invention also provides pharmaceutical compositions comprising these biaryl- containing inverse agonists, and methods of modulating ROR-gamma receptors using these inverse agonists. Also provided are methods of using biaryl-containing inverse agonists to treat ROR-gamma mediated diseases.